国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (18): 3045-3052.DOI: 10.3760/cma.j.cn441417-20240101-18011

• 论著 • 上一篇    下一篇

基于网络药理学和分子对接探究当归补血汤治疗缺铁性贫血的作用机制

陈超1  黎燕玲2  麦东媚1  蔡栋昊1   

  1. 1广东省第二中医院检验科,广州 510095;2中山大学孙逸仙纪念医院输血科,广州 510120

  • 收稿日期:2025-02-08 出版日期:2025-09-15 发布日期:2025-09-26
  • 通讯作者: 蔡栋昊,Email:583795382@qq.com
  • 基金资助:

    广东省医学科学研究基金(B2023187);广东省中医药局课题(20251026)

Mechanism of Danggui Buxue Decoction in treatment of iron deficiency anemia based on network pharmacology and molecular docking

Chen Chao1, Li Yanling2, Mai Dongmei1, Cai Donghao1   

  1. 1 Department of Clinical Laboratory, Guangdong Second Traditional Chinese Medicine Hospital, Guangzhou 510095, China; 2 Department of Blood Transfusion, Sun Yat⁃sen Memorial Hospital, Sun Yat⁃sen University, Guangzhou 510120, China

  • Received:2025-02-08 Online:2025-09-15 Published:2025-09-26
  • Contact: Cai Donghao, Email: 583795382@qq.com
  • Supported by:

    Medical Science Research Foundation of Guangdong Province (B2023187); Project of Guangdong Provincial Department of Traditional Chinese Medicine (20251026)

摘要:

目的 基于网络药理学和分子对接技术探究当归补血汤治疗缺铁性贫血的作用机制。方法 通过中药系统药理学数据库与分析平台(TCMSP)和文献阅读筛选黄芪和当归的有效成分和作用靶点,并结合Swiss Target Prediction数据库筛选药物有效靶点。通过GeneCards数据库获取缺铁性贫血相关靶点。通过药物靶点和疾病靶点交集,获得关键靶点。通过David数据库进行基因本体(GO)功能注释和京都基因与基因组百科全书(KEGG)通路富集分析。根据通路富集分析结果绘制“药物-成分-靶点-通路”图,并得到关键活性成分及其核心作用靶点。采用MOE软件对关键活性成分和核心靶点进行分子对接验证。结果 本研究共纳入30个有效成分及其对应661个靶点,疾病靶点939个,取二者交集点,得到110个关键靶点。槲皮素、山柰酚、3,9-di-O-methylnissolin、顺式阿魏酸4个有效成分为当归补血汤治疗缺铁性贫血的关键活性成分。磷酸肌醇3-激酶调节亚基1(PIK3R1)、RAC-α丝氨酸/苏氨酸蛋白激酶(AKT1)、转录因子p65(RELA)、丝裂原活化蛋白激酶1(MAPK1)、丝裂原活化蛋白激酶14(MAPK14)等15个靶点为其对应的核心作用靶点。其可能通过晚期糖基化产物(AGE)-晚期糖基化终末产物受体(RAGE)信号通路、缺氧诱导因子-1(HIF-1)信号通路等多个信号通路发挥作用。分子对接显示主要活性成分及相应核心作用靶点具有较好的结合活性。结论 当归补血汤是中医治疗缺铁性贫血的有效药物,可通过多个靶点、多种信号通路发挥作用。

关键词:

缺铁性贫血, 当归补血汤, 网络药理学, 分子对接

Abstract:

Objective To explore the mechanism of Danggui Buxue Decoction in the treatment of iron deficiency anemia based on network pharmacology and molecular docking technology. Methods The active components and targets of Astragalus and Angelica sinensis were screened by the Traditional Chinese Medicine Systems Pharmacology (TCMSP) and reading literature, and the effective targets were screened by the Swiss Target Prediction database. The targets of iron deficiency anemia were obtained from the GeneCards database. Through the intersection of drug targets and disease targets, the key targets were obtained. Gene ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed using the David database. According to the enrichment results of the pathways, the "drug-component-target-pathway" map was drawn, and the key active ingredients and their core targets were obtained. The MOE software was used to verify the molecular docking of the key components and core targets. Results A total of 30 active ingredients and their corresponding 661 targets and 939 disease targets were included in this study, and 110 key targets were obtained by the intersection of the two. Quercetin, kaempferol, 3, 9-di-o-methylnissolin, and cis-ferulic acid were the key active ingredients of Danggui Buxue Decoction in the treatment of iron deficiency anemia. Fifteen targets, including phosphoinositol 3-kinase regulatory subunit 1 (PIK3R1), RAC-alpha serine/threonine-protein kinase (AKT1), transcription factor p65 (RELA), mitogen-activated protein kinase 1 (MAPK1), MAPK14, etc., were the corresponding core action targets. It might play a role through several signaling pathways, such as the advanced glycation endproducts (AGE)-receptor for advanced glycation endproducts (RAGE) signaling pathway and HIF-1 signaling pathway. The molecular docking showed that the key active ingredients and the corresponding core target had good binding activity. Conclusion Danggui Buxue Decoction is an effective traditional Chinese medicine for iron-deficiency anemia, and exert its effects through multiple targets and various signaling pathways.

Key words:

Iron deficiency anemia, Danggui Buxue , Decoction, Network pharmacology, Molecular docking